Timothy L Jackson
King's College Hospital NHS Trust · Kings College London & Kings College Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Timothy L Jackson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:11 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06035887 · Novel ERG for Detection of Hydroxychloroquine RetinopathyKing's College Hospital NHS Trust · recruiting · Hydroxychloroquine Retinopathy · study chair
- Ph3NCT04663750 · Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).King's College Hospital NHS Trust · recruiting · Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage · principal investigator
- Ph3NCT02243878 · Stereotactic Radiotherapy for Wet AMD (STAR)King's College Hospital NHS Trust · completed · Neovascular (Wet) Age-related Macular Degeneration (AMD) · principal investigator
- N/ANCT02174211 · A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.King's College Hospital NHS Trust · completed · Age Related Macular Degeneration · principal investigator
- Ph2/Ph3NCT01835067 · Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMDKing's College Hospital NHS Trust · completed · Exudative Macular Degeneration, Retinal Hemorrhage · principal investigator
- N/ANCT01024803 · Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind PatientsRetina Implant AG · completed · Retinitis Pigmentosa, Retinal Degeneration · principal investigator
- Ph4NCT01006538 · Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)King's College Hospital NHS Trust · completed · Macular Degeneration · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:11 UTC. The ranking covers the 200 most relevant of 37 PubMed records, and a shared surname and initials can bring in a namesake. All 37 on PubMed
- Subretinal Visual Implant Alpha IMS--Clinical trial interim report.Vision Res · 2015263 citationsRCR 10.6
- A multi-institutional randomized controlled trial of adjuvant Web-based teaching to medical students.Acad Med · 200658 citationsRCR 2.5
- Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET).Ophthalmology · 201356 citationsRCR 2.5
- Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study.Ophthalmology · 201353 citationsRCR 2.4
- A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.Ophthalmology · 202351 citationsRCR 6.3
- 49 citationsRCR 1.1
- Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children.Am J Clin Nutr · 199547 citationsRCR 2.3
- Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers.Cancer Chemother Pharmacol · 201445 citationsRCR 1.2
- Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study.JAMA Ophthalmol · 201742 citationsRCR 2.0
- Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study.Ophthalmology · 201539 citationsRCR 2.1